THE SCIENCE BEHIND LEMBAS
From platform to benchmark to stomach
Lembas discovers food-grade bioactive peptides using a proprietary platform that combines edible peptide databases, receptor mapping, AI-guided discovery, and biological validation.
Our first proof-of-platform case study is Lembas Edge™, designed to engage the body’s native gut signaling biology and support satiety through endogenous hormone pathways.
FOOD-GRADE PEPTIDES.
PHARMA-GRADE DISCOVERY.
The GLP-1 era has changed how the world thinks about appetite, satiety, and metabolic health.
Lembas is bringing a pharma-grade discovery and validation mindset into food and supplements, using AI and high-throughput biology to identify natural peptides with measurable effects on gut signaling and satiety.
BY THE NUMBERS
10B+
Edible peptide sequences mapped
100+
Gut GPCRs
mapped
85%
Candidate validation
hit-rate
<12 MO
Discovery to
human-study path
-9.4
Predicted binding energy
(kcal/mol)
94.2%
Structural
confidence
Platform and candidate metrics based on internal Lembas discovery programs
FOUR PROPRIETARY CAPABILITIES.
ONE DISCOVERY ENGINE.
A proprietary library of food-derived peptide sequences mapped from edible proteomes and screened for biological relevance, safety, solubility, stability, and developability.
A structural and biological map of gut nutrient-sensing receptors involved in satiety, appetite regulation, and metabolic signaling, including pathways connected to GLP-1, PYY, GIP, insulin, leptin, and related hormones.
An AI-guided discovery engine that designs, ranks, and optimizes peptide candidates for receptor interaction, predicted activity, stability, solubility, and food-format compatibility.
A wet-lab validation system that tests whether predicted peptides actually activate relevant gut pathways, beginning with in vitro hormone secretion assays and advancing top candidates into in vivo models.
THE LEMBAS AI
DISCOVERY ENGINE
Every Lembas program moves through a closed-loop system that connects computational discovery with biological validation.
MAP THE BIOLOGY
Identify gut receptors and hormone pathways linked to the target health outcome
DISCOVER & RANK PEPTIDES
Search edible peptide space and use the Lembas AI Engine to prioritize the strongest candidates
VALIDATE IN
BIOLOGY
Test candidates in high-throughput assays and advance top performers into in vivo models
BUILD FOR REAL
LIFE
Develop lead peptides for food, supplement, and consumer product formats
LEMBAS EDGE™
CASE STUDY
The first proof-point from the Lembas AI platform.
Lembas Edge™ is a food-grade bioactive peptide designed to engage the gut's native nutrient-sensing biology and support satiety through endogenous hormone signaling.
In preclinical studies, Lembas peptides increased satiety-related hormones and reduced food intage and boxy weight in a diet-induced obseity model. The program was benchmarked against semaglutide as a pharmacological reference point.
DESIGNED
IN SILICO
VALIDATED IN
GUT BIOLOGY
TESTED
IN VIVO
Identified and prioritized using
the Lembas
AI Engine
Screened for
GLP-1 secretion in
gut endocrine cell
models
Evaluated in preclinical models measuring hormone response, food intake, and body weight
PRECLINICAL VALIDATION SNAPSHOT
1. BODY WEIGHT CHANGE (DIO RAT STUDY)
WHAT YOU'RE SEEING
Lembas peptides reduced body weight compared with vehicle in a DIO rat model
WHY IT MATTERS
This shows the platform can move from computational prediction to measurable in vivao metabolic effects.
2. CUMULATIVE FOOD INTAKE (DIO RAT STUDY)
WHAT YOU'RE SEEING
Lead peptides reduced cumulative food intake over the study period.
WHY IT MATTERS
The effect is connected to actual feeding behavior, not only receptor modeling or isolated cell data.